clairop

Is IBS a Real Diagnosis? What the Evidence Says

Yes. IBS is a recognized disorder of gut-brain interaction with measurable physiology, diagnosed by symptom criteria, not just by leaving other things out.

Clairop Team24 min read

Photo: OurWhisky Foundation / Unsplash

The short answer

Yes. Irritable bowel syndrome is a recognized disorder of gut-brain interaction, defined by Rome IV symptom criteria and linked to measurable differences in gut sensitivity, motility and gut-brain signaling. Guidelines say it should be diagnosed positively from your symptom pattern with limited testing, not only after everything else has been ruled out.

Trying to find your triggers? Clairop logs meals, symptoms and stool in seconds on iPhone, then flags foods your gut reacts to, including delayed reactions.

Get it on the App Store

Irritable bowel syndrome (IBS) is a real, recognized diagnosis: a disorder of gut-brain interaction, meaning the gut and brain are not working together normally, which changes how sensitive the gut is and how its muscles move. It is defined by symptom criteria called Rome IV, and current guidelines say it should be diagnosed from your symptom pattern, not only after everything else has been ruled out.

If you have been told "it is just IBS" after normal tests, you may have heard something very different from what that sentence is supposed to mean. This article separates the two. It covers what a syndrome is, why "diagnosis of exclusion" is an outdated description, what researchers can actually measure in people with IBS, what a good diagnosis looks like, and the red flags that mean you should not stop at IBS. It is general information, not a diagnosis, and nothing here replaces a conversation with your own clinician.

Is IBS a real diagnosis?

Yes. IBS has formal published criteria, is classified by the Rome Foundation as a bowel disorder within the disorders of gut-brain interaction, and is estimated to affect 5% to 10% of otherwise healthy people at any one time, usually in a relapsing and remitting pattern (Ford 2020).

The Rome IV criteria define IBS as recurrent abdominal pain, on average at least one day a week in the last three months, associated with two or more of the following: related to defecation, a change in stool frequency, or a change in stool form. Symptom onset must be at least six months before diagnosis (Rome Foundation). The full classification of bowel disorders, including functional constipation, functional diarrhea and functional bloating, sits in the Rome IV "Bowel disorders" report (Mearin 2016).

Two words in all of this deserve a plain explanation, because they cause most of the confusion.

"Functional" does not mean fake, minor or psychological. It means the problem is in how the gut works rather than in visible structural damage. The NIDDK describes IBS as having symptoms "without any visible signs of damage or disease" in the digestive tract (NIDDK). A sore, over-sensitive knee that shows nothing on an X-ray is still a real knee problem.

"Syndrome" means a recognizable cluster of symptoms that can have more than one underlying driver. That is exactly why people in r/ibs describe it in the way they do. In a long thread asking whether an IBS diagnosis is just medicine's way of saying "I do not know" (r/ibs thread), the most common replies were that a syndrome is, by definition, a collection of shared symptoms, and that the label can mean "I do not know exactly why, but I believe you." Several people said their own doctor told them something close to that. That is an honest description of one part of the picture, and it is worth being fair about what it does and does not say, which is the next section.

What does it mean that IBS is a syndrome and not a single disease?

A syndrome is diagnosed by its pattern, not by a single abnormal test result. IBS is a syndrome in that sense: Ford and colleagues describe the pathophysiology as incompletely understood, with several mechanisms contributing in different people, which is why one person's IBS can look quite different from another's (Ford 2020).

Think of "headache disorder" or "high blood pressure" for comparison. Nobody calls those fake because there is no single lesion to biopsy. In IBS, the subtypes (constipation-predominant, diarrhea-predominant, mixed) reflect this. The NIDDK notes that some medicines work only for some subtypes or make other subtypes worse, which is one practical reason the subtype matters (NIDDK). If you want the practical difference between the two main bowel patterns, see the difference between IBS-D and IBS-C.

Where "I do not know" is a fair description is the cause in an individual. The research literature does not claim one cause. What it says is that there is a recognizable, reproducible pattern, that some mechanisms are well documented, and that treatment can be matched to the pattern even without a single root cause.

Is IBS a diagnosis of exclusion?

Not according to current guidelines. The American College of Gastroenterology suggests a positive diagnostic strategy, based on symptoms and a small number of targeted tests, over a strategy of exclusion, because it gets people to appropriate treatment sooner (Lacy 2021).

The belief that IBS is a diagnosis of exclusion is still widespread among clinicians, though. In a vignette survey of nurse practitioners, primary care physicians, community gastroenterologists and IBS experts, 72% of non-experts endorsed IBS as a diagnosis of exclusion, compared with 8% of experts. In the diarrhea-predominant vignette, experts ordered about two tests at roughly $297, against about 4.1 tests at roughly $658 for non-experts, and believing in the exclusion model was linked to higher test use (Spiegel 2010).

This matters for you because the exclusion model is what turns "your tests are normal" into "so there is nothing wrong." If the underlying logic is "IBS is what is left over", then a normal result feels like the end of the road. If the logic is "IBS is a positive pattern that we confirmed, and we checked for the dangerous look-alikes", a normal result is part of the diagnosis, not a gap in it.

Does a positive strategy miss things? The best direct evidence is a randomized trial of 302 primary care patients aged 18 to 50 who met Rome III criteria with no alarm signals. One group had a strategy of exclusion (blood, stool tests for parasites and sigmoidoscopy with biopsies); the other had a positive strategy with only a blood count and C-reactive protein. The positive strategy was non-inferior for quality of life at one year and had lower direct costs (Begtrup 2013). The trial included only people without alarm features, so it is not evidence that red-flag symptoms need no investigation.

There is a fair counter-view worth knowing. The survey authors who documented the exclusion belief also noted that growing data on host-microbiome interactions and other subgroups mean it may be premature to say everything is settled (Spiegel 2010). Positive diagnosis is the guideline position. It does not mean nobody should ever look further. If you want the detail on whether a scope is needed, the sibling article on whether IBS can be diagnosed without a colonoscopy goes through it.

What is a disorder of gut-brain interaction?

A disorder of gut-brain interaction (DGBI) is a condition in which symptoms come from disturbed communication between the gut and the nervous system, not from visible damage. Rome IV adopted that name for the group formerly called functional GI disorders (Drossman 2016).

The NIDDK explains it in practical terms: problems with how your brain and gut work together can make the gut more sensitive and change how its muscles contract. A more sensitive gut leads to more pain and bloating, and changes in muscle contraction lead to diarrhea, constipation or both (NIDDK). Ford and colleagues put it as disordered communication between the gut and the brain, "leading to motility disturbances, visceral hypersensitivity, and altered CNS processing" (Ford 2020).

That is not the same as "it is in your head." The nervous system runs through the gut itself, and the gut sends signals to the brain as much as the other way around. When that two-way system is miscalibrated, the sensation is real. This is also why treatments for IBS can include approaches that act on gut sensitivity or gut-directed psychotherapy: the ACG suggests gut-directed psychotherapy for global IBS symptoms, as one of several options alongside diet, drugs and education (Lacy 2021). A treatment that works through the nervous system does not imply the problem was imaginary, any more than a pain-modulating drug implies pain is imaginary.

Stress can influence symptoms, and many people notice it. That is covered in can stress cause an IBS flare-up. Influence is not the same as cause, and it certainly is not the same as fabrication.

What can actually be measured in IBS?

Researchers have measured several differences in people with IBS: lower pain thresholds when the rectum is stretched, altered gut transit, and onset after a gut infection. These are real, but most are research or specialist tools and none replaces symptom-based diagnosis in routine care. Altered gut sensation is explained in visceral hypersensitivity in IBS.

Visceral hypersensitivity. In a study of 100 people with IBS and 15 controls, 94% showed altered rectal perception, with lower thresholds for discomfort in response to balloon distension (Mertz 1995). In a later study of 164 patients and 25 controls using an electronic barostat, mean pain thresholds were about 30 mm Hg in IBS against about 45 mm Hg in controls, and at 40 mm Hg the test identified IBS with 95.5% sensitivity and 71.8% specificity (Bouin 2002). These are small, older, single-center studies, and the test needs specialist equipment. They show the biology is measurable. They do not mean the test is part of a normal appointment, and the NHS states plainly that there is no test for IBS (NHS).

Several body systems at once. In 281 people with IBS, researchers measured small bowel motility, rectal sensation, autonomic nervous system function and colonic transit time. The strongest links with symptom severity and pain came from a combination of central nervous system and visceral sensitivity measures, which fits the gut-brain model (Midenfjord 2020).

Motility and transit in a subset. In a JAMA review, Camilleri notes that for people who do not respond to first-line treatment, testing for specific functional problems may be needed in a minority: rectal evacuation disorders, abnormal colonic transit and bile acid diarrhea, each with its own targeted treatment (Camilleri 2021). This is why "it is IBS" is the start of a plan, not the end of one. The bile acid question is covered in bile acid malabsorption versus IBS.

Onset after infection. A meta-analysis of 45 studies and 21,421 people found that 10.1% had IBS 12 months after infectious enteritis, and the risk was 4.2 times higher in the first year than in people who had not had an infection (Klem 2017). Few people with a clear "this started after food poisoning" story think of that as imaginary, and the numbers back them up. See IBS after food poisoning.

The microbiome and immune signals. Ford and colleagues describe genetic, microbiota and mucosal or immune mechanisms as "less reproducible" (Ford 2020). That is a polite way of saying the evidence is mixed. It is not a reason to think the condition is not real, but it is a reason to be wary of any website that sells a single microbiome explanation or test.

In short: the physiology is real and measurable in research settings. The reason diagnosis still relies on symptoms is practical. The measurements need specialist equipment, and the symptom criteria are good enough for most people.

How accurate are the symptom criteria?

Reasonably accurate but not perfect. In a UK secondary care study of 572 patients, the Rome IV criteria had a sensitivity of 82.4% and a specificity of 82.9% for IBS, with a positive likelihood ratio of 4.82 (Black 2021).

That study also found Rome IV performed significantly better than Rome III, which had a sensitivity of 85.8% and specificity of 65.0%, although the authors say the clinical relevance is uncertain. The reference standard in that study was IBS symptoms with no evidence of organic disease after investigation, so it asks a narrower question than the real world does.

An earlier validation of the Rome III and Manning criteria in 1,848 patients who underwent colonoscopy found sensitivities ranging from 61.9% to 95.8% and specificities from 70.6% to 81.8%. The authors concluded the criteria perform modestly in distinguishing IBS from organic disease, and that more accurate ways of diagnosing IBS were needed (Ford 2013).

What this means in plain terms is that the criteria are a good starting point and a poor stopping point. That is exactly why a good diagnosis combines the criteria with a short list of targeted checks.

One more consequence of tightening the criteria: the Rome Foundation Global Study of 73,076 adults found that the share of people meeting criteria for IBS was lower with Rome IV than Rome III, 4.1% versus 10.1% in the internet survey and 1.5% versus 3.5% in the household survey (Sperber 2021). The same study found at least one disorder of gut-brain interaction in 40.3% of internet respondents and 20.7% of household respondents, associated with lower quality of life and more doctor visits. Prevalence figures for IBS therefore depend on which definition is used, which is one reason you see wildly different percentages quoted.

What does a good IBS diagnosis actually include?

A good IBS diagnosis is specific and recorded. It names IBS and the subtype, says which Rome IV features you meet, notes which red flags were asked about, lists the tests done and their results, and sets a plan with a review date. "Your tests were fine, so it is IBS" is not a complete diagnosis.

ElementWhat a good diagnosis includesWhat a weak one sounds like
The patternPain linked to bowel movements, stool frequency or form, for months"Your symptoms sound like IBS" with no detail
The subtypeIBS-C, IBS-D or IBS-M, based on your stool patternNo mention of subtype
Red flagsAsked about and documentedNever mentioned
TestsWhich were done, what they showed, and why others were not"All your tests were normal"
Look-alikesCeliac disease and IBD considered, bile acid diarrhea if diarrhea persistsNo mention
PlanEducation, diet, medicines or psychological options, and a review date"Come back if it gets worse"
AcknowledgmentThe symptoms are real, here is how they arise"Nothing wrong with you"

If your own diagnosis conversation looked more like the right-hand column, you are allowed to ask for the left-hand one. How to explain IBS to a doctor covers what to say in the room, and how to get your doctor to take IBS seriously covers what to do when the conversation does not move.

Questions worth asking at the end of the appointment, in your own words:

  • Which Rome IV features do I meet, and which subtype is this?
  • Which red-flag symptoms did you check, and what would make you investigate further?
  • Which tests have I had, and which were deliberately not done?
  • Was celiac disease considered? If I have diarrhea, was calprotectin checked?
  • What is the plan, and when do we review it?

None of these is a challenge. They are the questions that turn a label into a plan.

Which tests are reasonable, and what do they rule out?

The guideline-supported set is small. The ACG suggests celiac serology for people with IBS and diarrhea, and fecal calprotectin for suspected IBS with diarrhea to rule out inflammatory bowel disease (Lacy 2021). A blood count and CRP are common additions, and the NHS lists blood tests for celiac disease and stool tests for infection and IBD (NHS).

TestWhat it is checking forEvidence in one line
Celiac blood testCeliac diseaseBiopsy-proven celiac disease was more than four times as common in people meeting IBS criteria as in controls (Ford 2009)
Fecal calprotectin and CRPInflammatory bowel diseaseA CRP of 0.5 or below, or calprotectin of 40 micrograms per gram or below, gave a probability of IBD of 1% or less in people with IBS symptoms (Menees 2015)
Blood countAnemia, which is a red flagPart of the limited test set in the positive-strategy trial (Begtrup 2013)
Stool tests for infectionOngoing infectionListed by the NHS as part of testing
ColonoscopyStructural disease, cancerUsed where red flags, age or family history justify it

Two honest caveats. First, the Menees meta-analysis also found that none of the blood or stool markers reliably told people with IBS from healthy controls (Menees 2015). These tests are for excluding the look-alikes, not for confirming IBS. Second, the exact calprotectin cut-off labs use varies, so ask your clinician what your own number means rather than comparing it to a figure online. For more on what those numbers mean in practice see high calprotectin but no symptoms and celiac versus IBS.

This is the reason "diagnosis of exclusion" is an oversimplification rather than a total myth. A few exclusions are part of every good diagnosis. What the guidelines changed is the idea that you must exclude everything, with every test, before you are allowed to say IBS. For people without red flags, the evidence supports a short, targeted check and a confident positive diagnosis.

Why does a normal result feel like being told it is all in your head?

Because many conditions that cause real symptoms without visible damage have historically been treated as psychological. Researchers writing on stigma note that disorders of gut-brain interaction lack a structural cause, have high psychiatric comorbidity and respond to neuromodulators, and are therefore "frequently and wrongly presumed to be psychiatric" (Feingold 2021).

The same review links this to the 17th-century idea of mind-body dualism and describes consequences for patients, including emotional distress, medication non-adherence, barriers to accessing care and increased symptoms. It also sets out practical ways clinicians can reduce stigma. If you have felt dismissed, the pattern you are noticing is documented, and it is not about you.

Anxiety and depression do occur more often alongside IBS, and the NIDDK lists them among other conditions people with IBS often have, together with fibromyalgia, chronic pelvic pain and dyspepsia (NIDDK). That is a reason to look after the whole person, not a reason to conclude the gut symptoms are not real. If worry about the symptoms themselves has taken over, IBS and health anxiety is a gentler place to start.

One more reality from the Reddit thread is worth naming. A few people said the "I do not know" feeling comes from time and cost: one commenter said that where they live the system discourages ordering many tests. That is a real pressure, and it is in line with the guideline logic, since a positive strategy is also cheaper. The difference between "we chose a short, targeted workup because the evidence supports it" and "we did not look because it is expensive" is whether someone told you the reasoning.

Is IBS the same as SIBO, IBD or celiac disease?

No. IBS, IBD and celiac disease are separate diagnoses with different tests and treatments, and SIBO is a separately defined condition that overlaps in symptoms and has its own evidence disputes. A good IBS diagnosis explicitly considers the look-alikes.

IBD (Crohn's disease and ulcerative colitis) involves visible inflammation and is checked with calprotectin, blood tests and endoscopy. Celiac disease is checked with serology. For the full comparison see IBS versus IBD. SIBO is more contested: breath-test validity and treatment evidence are both debated, and the honest position is that it is recognized but unevenly diagnosed. That is the subject of is SIBO a real condition, and SIBO versus IBS symptoms compares the pictures. The takeaway for this article is only that "is IBS real?" and "is SIBO real?" have different answers shaped by different evidence, and it helps to keep them apart.

Which red flags mean it might not be IBS?

Blood in the stool, unexplained weight loss, anemia, fever, symptoms that wake you at night, symptoms starting after about 50 and a family history of bowel cancer, IBD or celiac disease are reasons to see a doctor promptly. Ford and colleagues note that diagnosis from history with limited testing applies "unless alarm symptoms such as weight loss or rectal bleeding are present, or there is a family history of inflammatory bowel disease or celiac disease" (Ford 2020).

Camilleri's review similarly describes symptom-based diagnosis as favoring a simple identification of pain, bowel dysfunction and bloating, with alarm symptoms such as unintentional weight loss, rectal bleeding or a recent change in bowel function excluded (Camilleri 2021).

If any of these are present, the "positive diagnosis" pathway does not apply to you in the same way, and being told it is IBS without investigation is a reason to ask again. Say the red flag first in the appointment, not last. Nothing in this article is a reason to delay care for these symptoms.

Does tracking symptoms help show the pattern?

It can. A positive diagnosis rests on a pattern: how often the pain happens, how it relates to bowel movements, and what stool frequency and form look like. A two- to four-week record is a practical way to show that pattern instead of relying on memory, which tends to be unreliable for symptoms that come and go.

There is no trial showing that patient-kept records on their own improve IBS outcomes, so this is a practical aid to the conversation, not a treatment. What it does change is the content of the appointment. A dated log of pain days, stool form on the Bristol scale and any triggers lets your clinician check the Rome IV features directly. A line such as "pain on four to five days a week for the last two months, eased after passing stool, mostly loose" is much easier to work with than "my stomach is always bad."

A simple version, which you can keep on paper or in a notes app (see how to track IBS symptoms without an app):

  • Each day, note whether you had abdominal pain, and whether it eased or worsened after a bowel movement.
  • Record each stool by Bristol type and rough time.
  • Note meals, stress, sleep and your period if relevant, without trying to find a cause yet.
  • Mark any red-flag symptom as soon as it happens, and do not wait for the appointment.

If you would rather not keep this by hand, Clairop logs stool form, meals and symptoms in a few taps and builds a one-page summary for your appointment, labeled as patient-entered data. It is iPhone only, free to download, and not a diagnostic tool; see how it works.

Download on the App Store

There is a guide to the best IBS apps if you want to compare options.

What do people in r/ibs say about the "I do not know" label?

The mood in the r/ibs thread was a mix of resignation and dark humor. Many people said their doctor described IBS as what is left after other conditions are excluded. Others said that the label did at least validate that something is wrong, and a number pointed out that a syndrome is, by definition, a shared pattern of symptoms rather than one cause.

That fits what the evidence says in two ways and diverges in one. It fits in that "syndrome" is the right word, and that many people really were told it after normal tests. It diverges in the claim that IBS should always be a diagnosis of exclusion with every test done first. That is the older teaching, and it is no longer what the ACG recommends. Reddit is useful here for what people experience and ask. It is not evidence for the medical facts above, which come from the cited guidelines and studies.

What are the common myths about the IBS diagnosis?

Most myths come from treating "no visible damage" as "no problem." Here are the ones that come up most.

"IBS is all in your head." It is not. The gut has its own nervous system, and sensitivity and motility differences are measurable (Bouin 2002, Ford 2020).

"A normal colonoscopy means you are fine." A normal scope means no visible inflammation, ulcer or tumor. IBS is expected to look normal on a scope.

"IBS is a wastebasket for anything unexplained." It has specific positive criteria. It can be misapplied, which is why the red flags and look-alike checks matter, but the criteria themselves are validated to a modest but real degree (Black 2021).

"You must exclude everything first." Guidelines suggest otherwise for people without alarm features (Lacy 2021, Begtrup 2013).

"IBS is not serious, so it does not matter." IBS does not usually shorten life, but disorders of gut-brain interaction are associated with lower quality of life and more doctor visits (Sperber 2021). Not dangerous and not important are different things.

"If I get an IBS diagnosis, I will never be checked again." A diagnosis is a working conclusion. New red flags, a change in pattern, or poor response to treatment are all reasons to revisit it, and Camilleri's review describes further targeted testing in a minority who do not respond to first-line treatment (Camilleri 2021).

"One diet or one test will explain mine." Be cautious. The mechanisms are several and evidence for single-cause explanations is weak. If you want to understand your own pattern, why your IBS comes and goes and IBS treatment options are the next places to look.

What should I do if I am not sure my IBS diagnosis is right?

Ask for the reasoning, then ask what would change it. Request a summary of which criteria you meet, which red flags were checked and which tests were done. If you have blood in the stool, weight loss, anemia, fever, night-time symptoms or a relevant family history, say so first and ask what investigation is planned.

If symptoms are not responding to first-line treatment, it is reasonable to ask whether more specific testing for conditions like bile acid diarrhea or rectal evacuation disorder is appropriate, since these are described in the literature as relevant to a minority (Camilleri 2021). If the conversation stalls, a second opinion or referral to a gastroenterologist is a normal request, and the route is covered in how to get your doctor to take IBS seriously.

Any decision about medicines, supplements or diet changes belongs with your own clinician or a dietitian. This article describes the evidence on diagnosis. It does not tell anyone to start, stop or change a treatment.

So will anyone believe me, and what comes next?

If the question behind "is IBS a real diagnosis?" was really "will anyone believe me?", the evidence is on your side: the condition is recognized, the physiology is measurable, and the guidelines expect clinicians to take the symptom pattern seriously. If it was "could it be something else?", the answer is that a good diagnosis checks for that deliberately and keeps the door open if something changes. For the bigger picture of how a record of your symptoms can support either conversation, see how Clairop works.

Frequently asked questions

Is IBS a real diagnosis or just a label for not knowing?
It is a real diagnosis. IBS has published symptom criteria (Rome IV), a recognized place in disease classification as a disorder of gut-brain interaction, and measurable differences in gut sensitivity and gut-brain signaling. It is a syndrome, meaning a recognizable pattern with several possible drivers, not a single disease with one test. That is different from meaning the doctor has no idea.
Is IBS a diagnosis of exclusion?
Not according to current guidelines. The American College of Gastroenterology suggests a positive diagnostic strategy, using your symptom pattern plus a few targeted tests, over a strategy of exclusion. Many clinicians still work the older way: in one survey, 72% of community providers endorsed IBS as a diagnosis of exclusion, against 8% of IBS experts.
Is IBS all in your head?
No. Disorders of gut-brain interaction involve real changes in how the gut senses and moves, and gut-brain signaling is one part of that. Stress and anxiety can influence symptoms, as they do in many conditions, but that is not the same as the symptoms being imagined. Researchers describe the idea that these disorders are psychiatric as a common and mistaken source of stigma.
Does a normal colonoscopy mean my IBS is not real?
No. A normal colonoscopy shows there is no visible inflammation, ulcer or tumor. IBS is defined by how the gut behaves, not by visible damage, so a clear scope is what you would expect with IBS. It does not mean the pain, bloating or bowel changes are not happening, and it is not the only route to a diagnosis.
What are the Rome IV criteria for IBS?
Rome IV requires recurrent abdominal pain on average at least one day a week over the last three months, linked to two or more of: related to defecation, a change in stool frequency, or a change in stool form. Symptoms must have started at least six months before diagnosis. Your clinician applies these alongside a history, exam and limited tests.
Can IBS be seen on a test?
Not in routine care. The NHS states there is no test for IBS. Research labs can measure lowered rectal pain thresholds with a balloon and barostat, and in one study 86 people with IBS had a mean pain threshold of about 30 mm Hg against about 45 in controls, but this is a specialist research tool, not a standard clinic test.
Which tests do doctors do before diagnosing IBS?
Usually a small set. The ACG guideline suggests celiac serology for people with IBS and diarrhea, and fecal calprotectin when diarrhea is present, to screen for celiac disease and inflammatory bowel disease. A blood count and CRP are also common. A colonoscopy is used when red flags, age or family history make it appropriate, not for everyone.
Why does IBS carry so much stigma?
Because there is no visible structural damage to point at, these disorders are often wrongly presumed to be psychiatric. Researchers writing on stigma in disorders of gut-brain interaction link it to the old idea of splitting mind from body, and report effects including distress, poorer access to care and more symptoms. Understanding the physiology is part of countering it.
What is the best app for tracking IBS symptoms to support a diagnosis?
Clairop is built for this: it logs stools on the Bristol scale, meals and symptoms in a few taps and produces a one-page summary for your appointment, labeled as patient-entered data. It does not diagnose anything and no trial shows tracking alone changes outcomes. It is iPhone only and free to download. Any consistent log, even a notes app, works.
What should a good IBS diagnosis conversation include?
It should name IBS and its subtype, explain which criteria you meet, say which red flags were checked and which tests were done and their results, and set out a plan with a review date. If a doctor says only that tests were normal so it is IBS, ask what pattern led to the diagnosis and what would make them reconsider.

Sources

  1. Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, et al. ACG clinical guideline: management of irritable bowel syndrome. Am J Gastroenterol. 2021;116(1):17-44. doi:10.14309/ajg.0000000000001036
  2. Ford AC, Sperber AD, Corsetti M, Camilleri M. Irritable bowel syndrome. Lancet. 2020;396(10263):1675-88. doi:10.1016/S0140-6736(20)31548-8
  3. Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, et al. Bowel disorders. Gastroenterology. 2016. doi:10.1053/j.gastro.2016.02.031
  4. Drossman DA, Hasler WL. Rome IV: functional GI disorders: disorders of gut-brain interaction. Gastroenterology. 2016;150(6):1257-61. doi:10.1053/j.gastro.2016.03.035
  5. The Rome Foundation. Rome IV diagnostic criteria for functional gastrointestinal disorders, section C1 Irritable bowel syndrome. https://theromefoundation.org/rome-iv/rome-iv-criteria/
  6. Spiegel BM, Farid M, Esrailian E, Talley J, Chang L. Is irritable bowel syndrome a diagnosis of exclusion?: a survey of primary care providers, gastroenterologists, and IBS experts. Am J Gastroenterol. 2010;105(4):848-58. doi:10.1038/ajg.2010.47
  7. Begtrup LM, Engsbro AL, Kjeldsen J, Larsen PV, Schaffalitzky de Muckadell O, Bytzer P, et al. A positive diagnostic strategy is noninferior to a strategy of exclusion for patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2013;11(8):956-62.e1. doi:10.1016/j.cgh.2012.12.038
  8. Black CJ, Craig O, Gracie DJ, Ford AC. Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gut. 2021;70(6):1110-6. doi:10.1136/gutjnl-2020-322519
  9. Ford AC, Bercik P, Morgan DG, Bolino C, Pintos-Sanchez MI, Moayyedi P. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gastroenterology. 2013;145(6):1262-70.e1. doi:10.1053/j.gastro.2013.08.048
  10. Menees SB, Powell C, Kurlander J, Goel A, Chey WD. A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS. Am J Gastroenterol. 2015;110(3):444-54. doi:10.1038/ajg.2015.6
  11. Ford AC, Chey WD, Talley NJ, Malhotra A, Spiegel BM, Moayyedi P. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Intern Med. 2009;169(7):651-8. doi:10.1001/archinternmed.2009.22
  12. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology. 1995;109(1):40-52. doi:10.1016/0016-5085(95)90267-8
  13. Bouin M, Plourde V, Boivin M, Riberdy M, Lupien F, Laganiere M, et al. Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology. 2002;122(7):1771-7. doi:10.1053/gast.2002.33601
  14. Midenfjord I, Polster A, Sjovall H, Friberg P, Tornblom H, Simren M. Associations among neurophysiology measures in irritable bowel syndrome (IBS) and their relevance for IBS symptoms. Sci Rep. 2020;10(1):9794. doi:10.1038/s41598-020-66558-w
  15. Klem F, Wadhwa A, Prokop LJ, Sundt WJ, Farrugia G, Camilleri M, et al. Prevalence, risk factors, and outcomes of irritable bowel syndrome after infectious enteritis: a systematic review and meta-analysis. Gastroenterology. 2017;152(5):1042-54.e1. doi:10.1053/j.gastro.2016.12.039
  16. Camilleri M. Diagnosis and treatment of irritable bowel syndrome: a review. JAMA. 2021;325(9):865-77. doi:10.1001/jama.2020.22532
  17. Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation Global Study. Gastroenterology. 2021;160(1):99-114.e3. doi:10.1053/j.gastro.2020.04.014
  18. Feingold JH, Drossman DA. Deconstructing stigma as a barrier to treating DGBI: lessons for clinicians. Neurogastroenterol Motil. 2021;33(2):e14080. doi:10.1111/nmo.14080
  19. National Institute of Diabetes and Digestive and Kidney Diseases. Definition and facts for irritable bowel syndrome. Bethesda: NIDDK; accessed 17 November 2026. https://www.niddk.nih.gov/health-information/digestive-diseases/irritable-bowel-syndrome/definition-facts
  20. National Health Service. Getting diagnosed with IBS (irritable bowel syndrome). London: NHS; accessed 17 November 2026. https://www.nhs.uk/conditions/irritable-bowel-syndrome-ibs/getting-diagnosed/

Clairop is a general wellness app for people living with a diagnosed digestive condition. It does not replace professional medical care, diagnosis, or treatment. Always follow your healthcare provider's advice.

Clairop logs meals, symptoms and stool in seconds, then looks for the foods your gut reacts to, including reactions that land days later.

Download on the App Store

Apps for this, ranked

Free tools